Evidence map›Paper›PMID 37868563›Full record

ReviewCureus2023

The Correlation Between Progesterone and Mammographic Density in Postmenopausal Women: A Systematic Review of the Literature and Meta-Analysis.

Ioannis Boutas, Adamantia Kontogeorgi, Nektarios I Koufopoulos, Abraham Pouliakis, Constantine Dimitrakakis, Dionysios T Dimas, Kyparissia Sitara, Sophia Kalantaridou, Fatih Durmusoglu

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ioannis BoutasBreast Unit, Rea Maternity Hospital, Athens, GRC.
Adamantia KontogeorgiThird Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, GRC.
Nektarios I KoufopoulosSecond Department of Pathology, National and Kapodistrian University of Athens, Athens, GRC.
Abraham PouliakisSecond Department of Pathology, National and Kapodistrian University of Athens, Athens, GRC.
Constantine DimitrakakisBreast Unit, First Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, GRC.
Dionysios T DimasBreast Unit, Athens Medical Center, Psychiko Clinic, Athens, GRC.
Kyparissia SitaraDepartment of Internal Medicine, "Elpis" General Hospital of Athens, Athens, GRC.
Sophia KalantaridouThird Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, GRC.
Fatih DurmusogluDepartment of Obstetrics and Gynecology, Istanbul Medipol International School of Medicine, Istanbul, TUR.
Athens Medical Center · GRGeneral Hospital of Athens Elpis · GRNational and Kapodistrian University of Athens · GRIstanbul Medipol University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Higher mammographic breast density in premenopausal and postmenopausal women is related to a higher breast cancer risk. In this review, we analyze the correlation between estrogen, progesterone, and mammographic density in postmenopausal women and clarify whether these findings are consistent across different types of mammographic breast density. We extracted data concerning mammographic density increases in the populations treated with estrogen-only hormone replacement therapy and those treated with estrogen and progestin hormone replacement therapy. Postmenopausal women treated with estrogen and progesterone regimens had a statistically significant lesser mammographic density increase than estrogen-only hormone replacement therapy regimens.

Indexed as

breast cancerestrogenmammographic densitypostmenopausalprogesterone

Identifiers

PMID37868563
PMCPMC10588543
OpenAlexW4386889693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.